E9Q.F GUANGDONG KANG.CO.LTD YC1
- Market cap
- EUR 58.2M
- P/E
- 4.4x
- P/B
- 0.29x
- ROE
- 6.6%
- Dividend yield
- 12.08%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is E9Q.F undervalued?
Graham numberThe Graham number of GUANGDONG KANG.CO.LTD YC1 cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
GUANGDONG KANG.CO.LTD YC1 fundamental analysis
No fundamental analysis for GUANGDONG KANG.CO.LTD YC1 yet.
GUANGDONG KANG.CO.LTD YC1 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About GUANGDONG KANG.CO.LTD YC1
Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People's Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers reproductive medicine; plastic and aesthetic surgery; and laser treatment services. In a…
Full company profileGUANGDONG KANG.CO.LTD YC1 financial statements
GUANGDONG KANG.CO.LTD YC1 annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.95B | 1.85B | 2.04B | 2.06B | 2.02B |
| Gross Profit | 353M | 261M | 364M | 322M | 369M |
| Operating Income | 139M | 38.8M | 121M | 45.9M | 119M |
| EBITDA | - | 234M | 306M | 225M | 298M |
| Net Income | 94.3M | 59.7M | 121M | 15.3M | 99.6M |
| EPS | 0.28 | 0.18 | 0.36 | 0.05 | 0.30 |
| Balance Sheet | |||||
| Total Assets | 2.70B | 2.72B | 2.62B | 2.74B | 2.68B |
| Total Liabilities | 1.23B | 1.20B | 1.13B | 1.28B | 1.15B |
| Shareholders' Equity | 1.43B | 1.50B | 1.42B | 1.44B | 1.51B |
| Cash & Short-term Investments | 237M | 264M | 305M | 243M | 233M |
| Cash Flow | |||||
| Operating Cash Flow | 333M | 221M | 204M | 280M | 283M |
| Capital Expenditure | 171M | 115M | 131M | 87.0M | 48.2M |
| Free Cash Flow | 162M | 106M | 73.3M | 193M | 234M |
| Ratios | |||||
| ROE | 6.6% | 4.0% | 8.5% | 1.1% | 6.6% |
| ROA | 3.5% | 2.2% | 4.6% | 0.6% | 3.7% |
| Net Profit Margin | 4.8% | 3.2% | 5.9% | 0.7% | 4.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
GUANGDONG KANG.CO.LTD YC1 dividends
- Dividend yield
- 12.08%
- Forward dividend
- 0.02 EUR
- Payout ratio
- 50.0%
- Ex-dividend date
- Jun 23, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 49.8M | 0.15 | 50.0% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns GUANGDONG KANG.CO.LTD YC1
- Insiders 62.95%
- Institutions 0.05%
- Public & others 37.01%
- Shares outstanding 84.4M
- Free float 58.3M
GUANGDONG KANG.CO.LTD YC1 company profile
- Company name
- GUANGDONG KANG.CO.LTD YC1
- Ticker
- E9Q.F
- ISIN
- CNE100002B55
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 3,593
- Fiscal year end
- December
- Address
- 1000 Dongguan Avenue, Dongguan, China
- Website
- kanghuagp.com
About GUANGDONG KANG.CO.LTD YC1
Guangdong Kanghua Healthcare Group Co., Ltd. primarily operates private hospitals in the People's Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers reproductive medicine; plastic and aesthetic surgery; and laser treatment services. In addition, it provides rehabilitation services to patients with physical or mental disabilities; treatments that replicate kidney's function to remove wastes in blood for patients with kidney disease or failure; and elderly care and training service for the disabled. Further, the company offers elderly healthcare services, including assisted living, adult daycare, long-term care, residential care, and hospice care to the aged patients. Additionally, it operates Kanghua Hospital, Renkang Hospital, and Kanghua Zhonglian Cardiovascular Hospital; and offers management, hospital management, and property holding; and healthcare management services. Guangdong Kanghua Healthcare Group Co., Ltd. was formerly known as Guangdong Kanghua Healthcare Co., Ltd. and changed its name to Guangdong Kanghua Healthcare Group Co., Ltd. in August 2024. The company was incorporated in 2002 and is based in Dongguan, China. Guangdong Kanghua Healthcare Group Co., Ltd. operates as a subsidiary of Dongguan Kanghua Investment Group Co., Ltd.
GUANGDONG KANG.CO.LTD YC1 management
8- Mr. Junyang WangExecutive Chairman of the Board · born 1982
- Mr. Wangzhi ChenCEO & Executive Director · born 1971
- Mr. Wai Hung WongExecutive Vice Chairman · born 1988
- Ms. Aiqin WangExecutive Director · born 1971
- Mr. Wai Hang Wong CPACFO, Joint Company Secretary & Secretary to the Board · born 1979
- Mr. Baizhi WangVice General Manager of Operation · born 1976
- Ms. Hing Ling Chau FCIS, FCS, L.L.M.Joint Company Secretary · born 1975
- Ms. Li ChenFinancial Controller · born 1971